This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Peri-, endo- and myocarditis, cardiomyopathy
  • /
  • 2014 ESC Guidelines on diagnosis and management of...
Guideline

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Read time: 1 mins
Last updated:29th Aug 2014
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy


The aim is to provide healthcare professionals with a practical diagnostic and treatment framework for patients of all ages and, as the majority of patients have a genetic cause for their disease, the Guidelines also consider the implications of a diagnosis for families and provide specific advice on reproduction and contraception.
Adoption of a purely morphological disease definition means that the number of possible aetiologies is considerable, particularly in young children. As it is impractical to provide an exhaustive compendium of all possible causes of HCM, the Guidelines focus on the most common genetic and non-genetic subtypes, but additional references for less common disorders are provided. Similarly, treatment recommendations focus largely on generic management issues but make reference to rare diseases when appropriate.

 

Read full guideline